KPRX

Conviction 88HealthcareScan · Thu, Jun 25, 2026

Inverted hammer

KPRX$2.55-1.54%

ResistanceSupportVol 14

Vol MA14 40.55K

Mar 26Apr 14May 1May 19Jun 8Jun 25

KIORA PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.kiorapharma.com ↗

Price2.55

Change-1.54%

Gap-1.54%

Rel volume6.20×

Avg volume36.89K

Avg $ vol95.58K

SMA 202.61

SMA 502.54

SMA 2002.32

Price vs 50+0.26%

Price vs 200+9.75%

MA stackbullish

50/200 cross—

Supertrendup · 2.33

RSI (14)49

MACD hist-0.01

MACD cross—

Stoch %K / %D45 / 52

ADX (14)24

+DI / −DI25 / 16

RSI divergence—

MACD divergence—

ATR %+5.30%

ADR %4.92%

52w high3.18

52w low1.80

From 52w high-19.81%

Above 52w low+41.67%

New 52w highNo

SqueezeOff

Bollinger width14.56%

%B0.34

Donchian pos28.89%

Donchian high2.87

Donchian low2.42

AVWAP (52w high)2.35

vs AVWAP high+8.53%

AVWAP (52w low)2.31

vs AVWAP low+10.26%

OBV trendDown

Chaikin MF (20)-0.43

Today vs 20d6.20×

Avg vol (14d)40.55K

Avg vol (20d)36.89K

Avg $ vol (20d)95.58K

Market cap11.3M

RS 3m (vs SPY)+13.47%

RS 6m (vs SPY)+12.17%

RS line new highNo

Trend template5/8

Technical rank62.9

1 week-0.78%

1 month-5.56%

3 months+25.00%

6 months+18.06%

1 year-16.94%

YTD+26.24%

P/E-1.04

P/B0.81

P/S—

P/FCF-1.12

EPS-2.64

Div yield—

ROE-77.76%

ROA-51.04%

Debt/Eq0.02

Current6.68

EV/EBITDA-0.05

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-401.42%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value624.28K

Revenue0

Net income-2.42M

Gross profit—

Free cash flow-10.07M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out4.43M

Employees13

ListedFri, Feb 13, 2015

Free float2.74M

Float %74.4%

Short interest18.09K

Days to cover0.5d

Short volume26.6%

Squeeze score19 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction88 / 100

Pattern quality—

Tech rank62.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KPRX

All disclosures →

No recent disclosed trades by Congress in KPRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KPRX

No recent insider (Form 4) filings in KPRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in KPRX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.